rct
    2012
    High Quality

    Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

    Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M

    Published in JAMA, Vol. 308 (17), pp. 1751-60

    Methodology

    Large randomized double-blind placebo-controlled trial of a daily multivitamin in male physicians over more than a decade of follow-up.

    Key Findings

    The multivitamin produced a small reduction in total cancer incidence but no reduction in major cardiovascular events or mortality.

    Conclusions

    Daily multivitamins do not prevent cardiovascular disease despite improving nutrient adequacy.

    Limitations

    Well-nourished male physicians; results may not generalise.

    Supplements Studied

    The multivitamin produced no reduction in major cardiovascular events or mortality

    Outcomes Measured

    The multivitamin produced a small reduction in total cancer incidence but no reduction in major cardiovascular events or mortality

    Related Health Concerns

    Study Details

    Year:2012
    Sample Size:14,641
    Duration:572 weeks
    Quality Score:9/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.